The world is facing a crisis in treating infectious diseases, with a scarcity of new antibiotics in development to treat the growing threat of drug-resistant “superbugs”. We need new strategies to reinvigorate the antibiotic pipeline. In this Viewpoint we discuss one such approach, encouraging the community of synthetic chemists to participate in testing chemical diversity from their laboratories for antimicrobial potential. CO-ADD, the Community for Open Antimicrobial Drug Discovery, offers free screening against five bacteria and two fungi with follow up hit confirmation and validation, all with no strings attached.
We are pleased to announce that the Community for Open Antimicrobial Drug Discovery (CO-ADD) has been awarded a not-for-profit Google Ad Grant worth USD $10,000 a month.
Google Ad Grants empowers not-for-profit organisations through in-kind AdWords advertising, to promote their missions and initiative on Google search result pages.
CO-ADD is a global initiative of The University of Queensland’s Institute for Molecular Bioscience and is funded by the Wellcome Trust and UQ.
CO-ADD mascot Malcom the MRSA is traveling the world with the CO-ADD team.
CO-ADD’s Mathilde Desselle and Alysha Elliott will be touring Singapore from 15-17 April 2015 for an exciting line-up of meetings and seminars with local universities and research institutes.
It was announced today in the National Health Performance Authority latest report: Australia’s major public hospitals have recorded a marked fall in the rate of healthcare-associated ‘Golden Staph’ bloodstream infections.